Metabolic (ion homeostasis, especially calcium and phosphate)
Bone
Specialized connective tissue with extracellular matrix able to calcify, containing collagen fibres, non-collagenous proteins, and hydroxyapatite crystals
Cell types within bone
Osteoblasts (bone forming cells)
Osteoclasts (bone resorbing cells)
Osteocytes (embedded in calcified bone matrix)
Bone lining cells (involved in bone remodelling)
Bone remodelling cycle (trabecular bone)
1. Resting surface
2. Bone resorption
3. Reversal phase (cement line formation)
4. Bone formation (osteoid)
5. Bone formation (osteoid-mineralisation front)
6. Resting surface (new packet)
Calcium
Essential for bone mineral deposition, muscle contraction, blood clotting, and nerve impulse transmission
Hypocalcaemia symptoms include paraesthesia, muscle spams, cramps, tetany, circumoral numbness, and seizures
Parathyroid glands
Regulate calcium and phosphate levels by secreting PTH in response to low calcium and high phosphate
Actions of PTH
Increases calcium reabsorption in renal distal tubule
Increases intestinal calcium absorption (via activation of vitamin D)
Increases calcium release from bone (stimulates osteoclast activity)
Decreases phosphate reabsorption
Parathyroid hormone (PTH)
84 amino acid peptide with biological activity in first 34 amino acids, half-life 8 mins, acts through PTHR1 G-protein-coupled receptor
PTH increases distal tubular reabsorption of calcium and stimulates production of the active form of vitamin D
PTH enhances bone resorption by stimulating osteoclasts
Hypocalcaemia
Makes parathyroid glands increase PTH secretion, which increases bone resorption, increases urinary phosphate, decreases urinary calcium, increases 1,25D3 production, and increases calcium and phosphate absorption
Hyperphosphatemia
Makes parathyroid gland increase PTH secretion, which increases bone resorption, increases urinary phosphate, decreases urinary calcium, increases 1,25D3 production, and increases calcium and phosphate absorption
Vitamin D
Essential in intestinal calcium absorption and calcium homeostasis, important in osteoblast differentiation/osteoclastogenesis to increase bone remodelling
Vitamin D or calcium deficiency leads to osteomalacia (low mineral content)
Vitamin D assay
Assesses 25(OH)D3, not the active 1,25D3 form
Calcitonin
Produced by thyroid c-cells, inhibits bone resorption by direct effect on osteoclasts, not essential for life
Caused by renal disease (increased phosphate, decreased activation of vitamin D)
Tertiary hyperparathyroidism
Long-standing secondary HPT leads to irreversible parathyroid hyperplasia
Vitamin D or calcium deficiency leads to osteomalacia (low mineral count) due to lack of mineralisation of osteoid
Rickets/osteomalacia
Rickets affects growing skeleton, osteomalacia affects adults, both result in weak, soft bone
Causes of rickets and osteomalacia include dietary/lack of sunlight, and rarely inherited defects
Renal osteodystrophy is caused by reduced renal mass leading to decreased urinary phosphate and 1,25D3 production, increased urinary calcium, hyperphosphatemia, hypocalcaemia, and increased PTH secretion
Osteoporosis
Loss of bone mass/density leading to increased fracture risk, gradual decline with age, rapid decline in post-menopausal women due to oestrogen deficiency
Long term consequences of spinal osteoporosis
Osteopaenic/osteoporotic (postmenopausal woman without fracture)
Established osteoporosis (postmenopausal woman with fracture)
Severe osteoporosis (postmenopausal woman with 2 or more fractures)